EUVIMEDEUVIMED entdecken
Open Access

In situ coagulation environment regulation–assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics

Ya-Xuan Zhu iD, Zhixin Chen iD, Yanling You iD, Yihan Chen, Wenjie Yu iD, Xue Guan iD, Piao Zhu, Jie Yang, Min Ge iD, Xiaojun Chen iD, Han Lin iD, Jianlin Shi iD

Science Advances · 06.02.2026 · 12 (6)

DOI: 10.1126/sciadv.aea4782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 06.02.2026. Verfasst von Ya-Xuan Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Med…. Hauptthemen laut MEDLINE: Thrombosis, Blood Coagulation, Silicon, Fibrinolytic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shanghai, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombotic disorders remain among the leading causes of global mortality, yet current thrombolytic therapies are limited by poor targeting specificity and inadequate microenvironmental modulation, resulting in suboptimal efficacy and serious side effects. Here, we developed a hydrogen-generating nanothrombolytic agent that enables enzymatic clot dissolution in combination with intelligent microenvironment reprogramming. Specifically, we assembled urokinase, a clinical thrombolytic drug, with hydrogenated silicene (SiH) nanosheet and fibrinogen, a substrate of coagulation reaction, to promote thrombolysis. Functionally, SiH nanosheet plays multiple roles in the nanothrombolytics: blocking the functional sites of urokinase to durably inhibit its activity in circulation to prevent systemic bleeding, followed by urokinase reactivation in response to SiH nanosheet self-degradation and prothrombotic microenvironment regulation through the in situ hydrogen generation, which mitigates the oxidative stress of vascular endothelial cells and inhibits their release of procoagulant factors. This microenvironment-adaptive thrombolysis strategy offers a promising paradigm for the precise management of thrombotic emergencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisBlood CoagulationSiliconFibrinolytic AgentsNanostructuresHumansHydrogenationUrokinase-Type Plasminogen ActivatorHydrogenThrombolytic TherapyFibrinogenAnimals

Substanzen

SiliconFibrinolytic AgentsUrokinase-Type Plasminogen ActivatorHydrogenFibrinogen

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Medicine, Tongji University, Shanghai 200072, P. R. China.
  • State Key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics Chinese Academy of Sciences, Shanghai 200050, P. R. China.
  • Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences, Shanghai 200050, P. R. China.
  • National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, P.R. China.
  • Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning 110042, P. R. China.

ORCID-Profile: Ya-Xuan Zhu, Zhixin Chen, Yanling You, Wenjie Yu, Xue Guan, Min Ge, Xiaojun Chen, Han Lin, Jianlin Shi

Förderung

  • Natural Science Foundation of Shanghai
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Youth Innovation Promotion Association of the Chinese Academy of Sciences

Zitieren

APA

Zhu, Y. X., Chen, Z., You, Y., Chen, Y., Yu, W., Guan, X., Zhu, P., Yang, J., Ge, M., Chen, X., Lin, H., & Shi, J. (2026). In situ coagulation environment regulation–assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics. Science Advances, 12(6). https://doi.org/10.1126/sciadv.aea4782

Vancouver

Zhu YX, Chen Z, You Y, Chen Y, Yu W, Guan X, et al. In situ coagulation environment regulation–assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics. Science Advances. 2026;12(6). doi:10.1126/sciadv.aea4782

BibTeX
@article{Zhu2026,
  author = {Zhu, Ya-Xuan and Chen, Zhixin and You, Yanling and Chen, Yihan and Yu, Wenjie and Guan, Xue and Zhu, Piao and Yang, Jie and Ge, Min and Chen, Xiaojun and Lin, Han and Shi, Jianlin},
  title = {In situ coagulation environment regulation–assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {6},
  doi = {10.1126/sciadv.aea4782}
}
Kostenlos starten →